Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log
![]() | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
August 24, 2024
editRenamed
edit- Antihypertensive drug renamed to Antihypertensive.
- Draft:JJC8-088 renamed to JJC8-088.
- Modafiendz renamed to Modafiendz.
- Draft:RDS03-94 renamed to RDS03-94.
Reassessed
edit- Lobeline (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
Assessed
edit- AZD2327 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Antihypertensive (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Top-Class. (rev · t)
- List of Lambda Kappa Sigma chapters (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Draft:Pranas Šimanauskas (talk) assessed. Importance assessed as NA-Class. (rev · t)
August 23, 2024
editRenamed
edit- Draft:LSN2463359 renamed to LSN2463359.
- SR-95103 renamed to Famiraprinium.
Assessed
edit- Famiraprinium (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- L-701324 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Ondelopran (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
August 22, 2024
editRenamed
edit- CRL-40,940 renamed to Flmodafinil.
- CRL-40,941 renamed to Fladrafinil.
Assessed
edit- Fladrafinil (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Flmodafinil (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Lazertinib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
August 20, 2024
editReassessed
edit- 3-Hydroxyaspartic acid (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Gamma-Hydroxybutyraldehyde (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Inosine pranobex (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
- PDE4 inhibitor (talk) reassessed. Quality rating changed from Redirect-Class to Start-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)
Assessed
editAugust 19, 2024
editRenamed
editReassessed
edit- Desmethylzopiclone (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
Assessed
edit- ADL-5859 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Beta Phi Sigma (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Gender-affirming hormone therapy (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
- Draft:JJC8-088 (talk) assessed. Importance assessed as NA-Class. (rev · t)
- Draft:LSN2463359 (talk) assessed. Importance assessed as NA-Class. (rev · t)
- Draft:Modafiendz (talk) assessed. Importance assessed as NA-Class. (rev · t)
- Draft:RDS03-94 (talk) assessed. Importance assessed as NA-Class. (rev · t)
- ZD-9379 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
August 18, 2024
editRenamed
edit- Draft:Desmethylzopiclone renamed to Desmethylzopiclone.
- Draft:RTI-5152-12 renamed to RTI-5152-12.
Reassessed
edit- Adewusi Michael Olufemi (talk) reassessed. Quality rating changed from Unassessed-Class to Redirect-Class. (rev · t) Importance rating changed from Unknown-Class to NA-Class. (rev · t)
- Catherine M. Cahill (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
- Monoaminergic activity enhancer (talk) reassessed. Quality rating changed from Unassessed-Class to B-Class. (rev · t)
Assessed
edit- CGP-39551 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- EF-1502 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Template:Monoaminergic activity enhancers (talk) assessed. Quality assessed as Template-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- ORG-24598 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- SR-95103 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- VU-0152100 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Virapinib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)